- Home
- ARQT vs TDC Comparison
ARQT vs TDC Comparison
Compare ARQT & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- TDC
- Stock Information
- Founded
- ARQT 2016
- TDC 1979
- Country
- ARQT United States
- TDC United States
- Employees
- ARQT N/A
- TDC N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- TDC Computer Software: Prepackaged Software
- Sector
- ARQT Health Care
- TDC Technology
- Exchange
- ARQT Nasdaq
- TDC Nasdaq
- Market Cap
- ARQT 2.0B
- TDC 2.3B
- IPO Year
- ARQT 2020
- TDC 2007
- Fundamental
- Price
- ARQT $13.80
- TDC $20.32
- Analyst Decision
- ARQT Strong Buy
- TDC Hold
- Analyst Count
- ARQT 6
- TDC 10
- Target Price
- ARQT $18.80
- TDC $31.56
- AVG Volume (30 Days)
- ARQT 2.6M
- TDC 2.2M
- Earning Date
- ARQT 05-13-2025
- TDC 05-05-2025
- Dividend Yield
- ARQT N/A
- TDC N/A
- EPS Growth
- ARQT N/A
- TDC 90.16
- EPS
- ARQT N/A
- TDC 1.16
- Revenue
- ARQT $196,542,000.00
- TDC $1,750,000,000.00
- Revenue This Year
- ARQT $60.21
- TDC N/A
- Revenue Next Year
- ARQT $40.21
- TDC $0.55
- P/E Ratio
- ARQT N/A
- TDC $17.30
- Revenue Growth
- ARQT 229.74
- TDC N/A
- 52 Week Low
- ARQT $6.99
- TDC $18.43
- 52 Week High
- ARQT $17.75
- TDC $38.45
- Technical
- Relative Strength Index (RSI)
- ARQT 46.44
- TDC 37.91
- Support Level
- ARQT $12.51
- TDC $20.00
- Resistance Level
- ARQT $13.67
- TDC $20.98
- Average True Range (ATR)
- ARQT 1.43
- TDC 0.96
- MACD
- ARQT -0.27
- TDC 0.03
- Stochastic Oscillator
- ARQT 34.83
- TDC 39.81
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About TDC Teradata Corporation
Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.